The FDA Just Crushed Sarepta Therapeutics' Hopes Of Releasing A Muscular Dystrophy Drug
January 21, 2016 at 11:23 AM EST
Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) saw a marked decline this week after Food and Drug Administration scientists said ...
